Preanalytical variables for liquid chromatography-mass spectrometry (LC-MS) analysis of human blood specimens

Clinical Biochemistry

Volumn 50, Issue 10-11, 2017, Pages 582-586

  Salvagno, Gian Luca ^a   Danese, Elisa ^a   Lippi, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Errors; LC MS; Mass spectrometry; Preanalytical phase; Standardization

Indexed keywords

BACTERIOSTASIS; BLOOD SAMPLING; CENTRIFUGATION; CIRCADIAN RHYTHM; DEMOGRAPHY; FREEZE THAWING; HEMOLYSIS; HUMAN; IN VITRO STUDY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; PRIORITY JOURNAL; PROTEOMICS; PURIFICATION; REVIEW; SPECIMEN HANDLING; BLOOD ANALYSIS; BLOOD STORAGE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCEDURES; STANDARDS;

BLOOD CHEMICAL ANALYSIS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY;

EID: 85018623268     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2017.04.012     Document Type: Review

References (41)

1. Plebani, M., EFLM Task Force on Performance Specifications for the extra-analytical phases, Performance specifications for the extra-analytical phases of laboratory testing: why and how. Clin. Biochem., 4, 2017 Feb, 10.1016/j.clinbiochem.2017.02.002.
2. Plebani, M., Quality in laboratory medicine: 50 years on. Clin. Biochem. 50 (2017), 101–104.
3. Lippi, G., Banfi, G., Church, S., Cornes, M., De Carli, G., Grankvist, K. et al., Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin. Chem. Lab. Med. 53 (2015), 357–370.
4. Lippi, G., Guidi, G.C., Mattiuzzi, C., Plebani, M., Preanalytical variability: the dark side of the moon in laboratory testing. Clin. Chem. Lab. Med. 44 (2006), 358–365.
5. Lippi, G., Bowen, R., Adcock, D.M., Re-engineering laboratory diagnostics for preventing preanalytical errors. Clin. Biochem. 49 (2016), 1313–1314.
6. Delvin, E., Laboratory medicine: advances and challenges. Clin. Biochem., 2016 Nov 19, 10.1016/j.clinbiochem.2016.11.021 (Epub ahead of print).
7. Lehmann, S., Hoofnagle, A., Hochstrasser, D., Brede, C., Glueckmann, M., Cocho, J.A. et al., Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. Clin. Chem. Lab. Med. 51 (2013), 919–935.
8. Božović, A., Kulasingam, V., Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins. Clin. Biochem. 46 (2013), 444–455.
9. Himmelsbach, M., 10 years of MS instrumental developments–impact on LC-MS/MS in clinical chemistry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 3–17 (2012), 883–884.
10. Carter, G.D., 25-Hydroxyvitamin D assays: the quest for accuracy. Clin. Chem. 55 (2009), 1300–1302.
11. Dunn, W.B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N. et al., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6 (2011), 1060–1083.
12. Lippi, G., Simundic, A.M., Rodriguez-Manas, L., Bossuyt, P., Banfi, G., Standardizing in vitro diagnostics tasks in clinical trials: a call for action. Ann Transl Med, 4, 2016, 181.
13. van Kerkhof, L.W., Van Dycke, K.C., Jansen, E.H., Beekhof, P.K., van Oostrom, C.T., Ruskovska, T. et al., Diurnal variation of hormonal and lipid biomarkers in a molecular epidemiology-like setting. PLoS One, 10, 2015, e0135652.
14. Yin, P., Lehmann, R., Xu, G., Effects of pre-analytical processes on blood samples used in metabolomics studies. Anal. Bioanal. Chem. 407 (2015), 4879–4892.
15. Ishikawa, M., Maekawa, K., Saito, K., Senoo, Y., Urata, M., Murayama, M. et al., Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. PLoS One, 9, 2014, e91806.
16. Minami, Y., Kasukawa, T., Kakazu, Y., Iigo, M., Sugimoto, M., Ikeda, S. et al., Measurement of internal body time by blood metabolomics. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 9890–9895.
17. Simundic, A.M., Cornes, M., Grankvist, K., Lippi, G., Nybo, M., Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin. Chim. Acta 432 (2014), 33–37.
18. Brauer, R., Leichtle, A.B., Fiedler, G.M., Thiery, J., Ceglarek, U., Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry. Metabolomics 7 (2011), 344–352.
19. Gibney, M.J., Walsh, M., Brennan, L., Roche, H.M., German, B., van Ommen, B., Metabolomics in human nutrition: opportunities and challenges. Am. J. Clin. Nutr. 82 (2005), 497–503.
20. Daskalaki, E., Blackburn, G., Kalna, G., Zhang, T., Anthony, N., Watson, D.G., A study of the effects of exercise on the urinary metabolome using normalisation to individual metabolic output. Meta 5 (2015), 119–139.
21. Pedersen, B.K., Febbraio, M.A., Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8 (2012), 457–465.
22. Bowen, R.A., Adcock, D.M., Blood collection tubes as medical devices: the potential to affect assays and proposed verification and validation processes for the clinical laboratory. Clin. Biochem. 49 (2016), 1321–1330.
23. Ellervik, C., Vaught, J., Preanalytical variables affecting the integrity of human biospecimens in biobanking. Clin. Chem. 61 (2015), 914–934.
24. Yin, P., Peter, A., Franken, H., Zhao, X., Neukamm, S.S., Rosenbaum, L. et al., Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. Clin. Chem. 59 (2013), 833–845.
25. Mei, H., Hsieh, Y., Nardo, C., Xu, X., Wang, S., Ng, K. et al., Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun. Mass Spectrom. 17 (2003), 97–103.
26. Barri, T., Dragsted, L.O., UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Anal. Chim. Acta 768 (2013), 118–128.
27. Denery, J.R., Nunes, A.A., Dickerson, T.J., Characterization of differences between blood sample matrices in untargeted metabolomics. Anal. Chem. 83 (2011), 1040–1047.
28. Bowen, R.A., Hortin, G.L., Csako, G., Otañez, O.H., Remaley, A.T., Impact of blood collection devices on clinical chemistry assays. Clin. Biochem. 43 (2010), 4–25.
29. Vogeser, M., Seger, C., Quality management in clinical application of mass spectrometry measurement systems. Clin. Biochem. 49 (2016), 947–954.
30. Lippi, G., Plebani, M., Di Somma, S., Cervellin, G., Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit. Rev. Clin. Lab. Sci. 48 (2011), 143–153.
31. Lippi, G., Salvagno, G.L., Montagnana, M., Brocco, G., Guidi, G.C., Influence of hemolysis on routine clinical chemistry testing. Clin. Chem. Lab. Med. 44 (2006), 311–316.
32. Kamlage, B., Maldonado, S.G., Bethan, B., Peter, E., Schmitz, O., Liebenberg, V. et al., Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin. Chem. 60 (2014), 399–412.
33. Mitra, V., Govorukhina, N., Zwanenburg, G., Hoefsloot, H., Westra, I., Smilde, A. et al., Identification of analytical factors affecting complex proteomics profiles acquired in a factorial design study with analysis of variance: simultaneous component analysis. Anal. Chem. 88 (2016), 4229–4238.
34. Hughes, N.C., Wong, E.Y.K., Fan, J., Bajaj, N., Determination of carryover and contamination for mass spectrometry-based chromatographic assays. AAPS J. 9:3 (2007), E353–E360.
35. ISO 15189:2012: Medical Laboratories-Requirements for Quality and Competence. Third edition.
36. Banfi, G., Lippi, G., The impact of preanalytical variability in clinical trials: are we underestimating the issue?. Ann Transl Med, 4, 2016, 59.
37. Cao, E., Chen, Y., Cui, Z., Foster, P.R., Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. Biotechnol. Bioeng. 82 (2003), 684–690.
38. Fliniaux, O., Gaillard, G., Lion, A., Cailleu, D., Mesnard, F., Betsou, F., Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks. J. Biomol. NMR 51 (2011), 457–465.
39. Bernini, P., Bertini, I., Luchinat, C., Nincheri, P., Staderini, S., Turano, P., Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J. Biomol. NMR 49 (2011), 231–243.
40. Hassis, M.E., Niles, R.K., Braten, M.N., Albertolle, M.E., Ewa Witkowska, H., Hubel, C.A. et al., Evaluating the effects of preanalytical variables on the stability of the human plasma proteome. Anal. Biochem. 478 (2015), 14–22.
41. Zimmerman, L.J., Li, M., Yarbrough, W.G., Slebos, R.J., Liebler, D.C., Global stability of plasma proteomes for mass spectrometry-based analyses. Mol. Cell. Proteomics, 11, 2012 (M111.014340).